Abbott Laboratories Company News

Old Arcived News About Abbott Laboratories

• 3 Stocks Dragging In The Health Services Industry.
• 5 Trade ideas for Monday: Abbott Labs, Capital One, FedEX, ARM Holdings and Nuance.
• Abbott (ABT) Stock Up, to Acquire Alere for $5.8 Billion.
• Abbott Agrees to Buy Alere for $5.8 Billion.
• Abbott Announces Early Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022. [PR Newswire] - ABBOTT PARK, Ill., Dec. 30, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today reported early results for the tender offer and related consent solicitation commenced by its wholly-owned subsidiary, Abbott Laboratories ...
• Abbott Announces Increase in Quarterly Dividend. [PR Newswire] - ABBOTT PARK, Ill., Dec. 12, 2014 /PRNewswire/ -- The board of directors of Abbott (ABT) today increased the company's quarterly common dividend to $0.24 per share from $0.22 per share. This marks the 364th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 13, 2015, to shareholders of record at the close of business on Jan. 15, 2015. This will mark the 43rd consecutive year the company has increased its dividend payout. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.
• Abbott Brings `Salted Decadence' Bars to Crowded Snack Aisle.
• Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022. [PR Newswire] - ABBOTT PARK, Ill., Dec. 15, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), ...
• Abbott Completes Acquisition of Topera, Inc.. [PR Newswire] - ABBOTT PARK, Ill., Dec. 22, 2014 /PRNewswire/ -- Abbott (ABT) today announced that it has completed its acquisition of Topera, Inc., a private, venture-backed medical device company focused on developing innovative electrophysiology technologies to improve the diagnosis and treatment of atrial fibrillation, one of the most common heart rhythm disorders in the world. Catheter-based electrophysiology is an approximately $3 billion global market that has been growing annually at double-digit rates. Topera has developed a novel diagnostic catheter and mapping software, or rotor identification system, which helps physicians identify and target patient-specific rotors that have been shown to be the sustaining mechanism for atrial fibrillation. The ability to locate these rotors enables the physician to individualize patient treatment through a procedure referred to as Focal Impulse and Rotor Mapping guided ablation, or FIRM-guided ablation.
• Abbott Completes Acquisition of Veropharm. [PR Newswire] - ABBOTT PARK, Ill., Dec. 12, 2014 /PRNewswire/ -- Abbott (ABT) today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commitment to growing global healthcare markets and capabilities, the company is committed to providing a reliable supply of its healthcare products to Russian patients. Through this acquisition, Abbott establishes a manufacturing footprint in Russia through Veropharm's production facilities, which include a new manufacturing facility currently under construction. Abbott also obtains a portfolio of medicines that is well aligned with its current pharmaceutical therapeutic areas of focus in women's health, central nervous system, cardiovascular and gastroenterology, while adding an offering in the field of oncology and pharmaceutical R&D capabilities for Russia.
• Abbott Drops as Earnings Forecast Falls Short on Strong Dollar.
• Abbott Laboratories.
• Abbott Laboratories (ABT) Is Today's Pre-Market Laggard Stock.
• Abbott Laboratories (ABT) Showing Unusual Social Activity Today.
• ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report.
• ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers.
• ABBOTT LABORATORIES Files SEC form 8-K, Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Fi.
• ABBOTT LABORATORIES Financials.
• Abbott Labs raises dividend to 24 cents.
• Abbott raises quarterly dividend to 24 cents a share from 22 cents.
• Abbott to Present at J.P. Morgan Healthcare Conference. [PR Newswire] - ABBOTT PARK, Ill., Dec. 18, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2015. Thomas C. Freyman, executive vice president, ...
• Abbott Wins Ruling Blocking NYC Subpoena Over Baby Formula Ads.
• Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe. [PR Newswire] - ABBOTT PARK, Ill., Dec. 11, 2014 /PRNewswire/ -- Abbott (ABT) today announced its innovative diagnostic platform, known as IRIDICA, is now available in Europe and other CE-Mark recognized countries. The new platform can identify more than 1,000 infection-causing pathogens in less than six hours, versus the current standard of care (culture-based testing), which can take days. By identifying the cause of infections – such as bacteria, viruses or fungi – sooner, doctors can improve care for the critically ill. "Doctors need better tools to diagnose people with serious infections," said Professor Francois Simon, M.D., Ph.D., Chief of Microbiology at Hopital Saint-Louis, Paris, France.
• Abbott's $5.8 Billion Deal for Alere Is Device Sector's Latest.
• Bulls can't get enough of Abbott Labs.
• Chilean businessman Bilbao fined $3.2 million for insider trading. [Reuters] - Chile's financial regulator said on Thursday it had fined Santiago-based businessman Juan Bilbao Hormaeche some $3.2 million for using insider information to trade shares of drug company CFR Pharmaceuticals SA. The move came about a month after the U.S. Securities and Exchange Commission reached a $13.2 million dollar settlement with Bilbao after alleging he engaged in insider trading ahead of Abbott Laboratories' $2.9 billion acquisition of CFR. In accusations similar to those presented by the SEC, Chile's SVS securities regulator said Bilbao acquired 707,222 American Depository Shares of CFR while serving as the company's director.
• Chilean quits company boards to fight U.S. insider trading charges. [Reuters] - A Chilean businessman charged by U.S. regulators with insider trading linked to Abbott Laboratories $2.9 billion acquisition of a pharmaceutical firm said on Tuesday he had quit several board positions ...
• Dividend Aristocrats Part 30: Abbott Laboratories.
• Drugs Stocks On The Rise With Help From 3 Stocks.
• France, Germany suspend some drug approvals over Indian data. [Reuters] - Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences, ...
• Goldman Is Downgrading Abbott Laboratories.
• Impact of Malnutrition in U.S. at $157 Billion Annually. [PR Newswire] - ABBOTT PARK, Ill., Dec. 4, 2014 /PRNewswire/ -- Even in food-abundant industrialized countries like the U.S., an alarming number of people, particularly seniors, are in a state of diseased-associated malnutrition ...
• Is Abbott Laboratories.
• March 14 Premarket Briefing: 10 Things You Should Know.
• Rush in Medical Device Investments: Should You Buy These Stocks?.
• Stocks Remain in Red as Crude Tumbles.
• Stocks Slide as Construction Spending Points to Weaker GDP.
• The Dollar and the Damage Done.
• The World's Top 10 Health Care Companies (UNH, MDT).
• Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says.
• TIMELINE-Mylan fails in $26 bln takeover bid for Perrigo. [Reuters] - Drugmaker Mylan NV's $26 billion hostile bid for Perrigo Co Plc failed on Friday, putting an end to the ongoing saga, which started more than seven months ago. Netherlands-based Mylan has made a number ...
• U.S. Stocks Climb Amid Earnings as Oil Jumps to Three-Week High.
• Zoetis: An attractive business model.
• [$$] Zoetis Lifts Outlook as Results Top Views.